Unleashing the Immune System: Treatment and Adverse Event Management for the Immuno-Oncology Patient
Recorded On: 08/22/2018
This presentation will discuss the clinical indications, administration, and adverse-event implications of novel immuno-oncology agents. As these therapies have emerged, it is evident that the side-effect profile and management of these agents are vastly different from traditional chemotherapy. Immuno-oncology-specific education for health care workers and patients is critical to the safe delivery and implementation of high-quality care. Throughout this presentation, the background of employing the immune system to fight cancer, and using real-patient scenarios to demonstrate best practices for infusion clinicians in the care, quality, and education of the immuno-oncology patient will be explored.
Learning Outcomes: At the conclusion of this presentation, participants will be able to:
- Identify 3 signs and symptoms of an immune-mediated adverse event.
- Discuss the importance of early identification and treatment of adverse events.
- Verbalize 3 different methods of education for immuno-oncology patients.
Megan Derr, MSN, RN, CMSRN, AONCS®
Megan Derr, MSN, RN, CMSRN, AONCS®, is an oncology quality and evidence-based practice specialist at the Lehigh Valley Cancer Institute in Allentown, Pennsylvania. She is certified by the Oncology Nursing Certification Corporation as an advanced oncology clinical nurse specialist. A highlight in her current role has been educating the cancer institute about immuno-oncology agents, their side effects, and adverse event management.
CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: August 22, 2021